Browse articles on EyeWorld.org from the Cornea section. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Cornea Editor Julie Schallhorn, MD, shared the topics covered in this section and her thoughts on the factors to consider with advancements, such as that of benefit to the patient vs. cost to the patient and the system.
U.S. ophthalmologists who have used the Epioxa system (Glaukos) for an epithelium-on crosslinking approach are excited to share their insights on this new option that they think will be safer for patients, facilitate faster healing, and could potentially stop progression of keratoconus sooner.
Blepharitis diagnosis and treatment have shifted in recent years, from the ability to diagnose blepharitis subtypes to the ability to treat those subtypes specifically. Overall, it’s becoming a more treatable ocular surface disease, and three experts had something to say about it.
Corneal tissues procedures are one of the approaches available to help treat corneal conditions, like keratoconus, and offer some patients an option other than transplantation. Several experts discussed these procedures, how they fit in with other options, and how they’re being utilized today.
Even though there are more tools than ever in ophthalmologists’ dry eye toolkits, how to use these tools and the expanded treatment options—and get payment for them—is still a mixed bag. Three physicians weighed in on the topic.
Before giving readers a preview of the articles in the Cornea section, Julie Schallhorn, MD, shared a recent experience with AI that got her thinking about the field of ophthalmology. “Tools that once demanded specialized training are now within reach of any curious user,” she said.
There are many available technologies in the ophthalmologist’s toolkit for the corneal practice. EyeWorld spoke to three ophthalmologists to get their thoughts on advanced imaging options in cornea, including some of the newer technologies.
Epithelial basement membrane dystrophy (EBMD) is a common corneal issue. Two experts discussed how this might present in patients and the number of treatment options available to address the condition, with surgeons often needing to use several different strategies.
“As we advance in medicine, the next frontier will be getting a true picture of the state of the patient—genetics, environment, and lifestyle—and using this to find the correct diagnosis and treatment,” said Julie Schallhorn, MD, as she introduced the articles in the Cornea section of the issue.
Biologics may dominate in the retina subspecialty, but cornea is beginning to see interest with these products as well, especially for immune-mediated or severe ocular surface diseases and even corneal dystrophies. Three physicians spoke to EyeWorld about the topic.
Get the latest ophthalmology news delivered to your inbox every Friday.